Investor Hub
Novavax, Inc. is a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases.
Form | Description | Date | Format |
---|---|---|---|
SC 13D/A | Amendment to a SC 13D filing | Jul 24, 2002 | ![]() ![]() ![]() ![]() |
SC 13G/A | Amendment to a previously filed SC 13G | Jan 25, 2002 | ![]() ![]() ![]() ![]() |
![]() |
Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings, and more.
![]() |
Shareholders seeking information can contact investor relations at (240) 268-2022 or email us at ir@novavax.com
Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.